Evidence map›Paper›PMID 40300640›Full record

ArticleRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin2026

Performance of AI Approaches for COVID-19 Diagnosis Using Chest CT Scans: The Impact of Architecture and Dataset.

Astha Jaiswal, Philipp Fervers, Fanyang Meng, Huimao Zhang, Dorottya Móré, Athanasios Giannakis, Jasmin Wailzer, Andreas Michael Bucher, David Maintz, Jonathan Kottlors and 2 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Astha JaiswalInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Philipp FerversInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Fanyang MengDepartment of Radiology, The First Hospital of Jilin University, Changchun, China.
Huimao ZhangDepartment of Radiology, The First Hospital of Jilin University, Changchun, China.
Dorottya MóréDepartment of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany.
Athanasios GiannakisDepartment of Diagnostic and Interventional Radiology, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany.
Jasmin WailzerInstitute for Diagnostic and Interventional Radiology, Frankfurt University Hospital, Frankfurt, Germany.
Andreas Michael BucherInstitute for Diagnostic and Interventional Radiology, Frankfurt University Hospital, Frankfurt, Germany.
David MaintzInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Jonathan KottlorsInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0001-5021-6895
Rahil ShahzadInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Thorsten PersigehlInstitute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0001-5928-4405

Funding

China International Medical Foundation, Imaging Research, SKY Z-2014-07-2003-03Jilin Provincial Key Laboratory of Medical imaging & big data 20200601003JCNIEHS NIH HHS 27398C0007RACOON (NUM), "NUM 2.0" FKZ: 01KX2121Radiology and Technology Innovation Center of Jilin Province 20190902016TCSino-German Center for Research Promotion (SGC), a project entitled CT-based Deep Learning Algorithm in Diagnosis and evaluation of COVID-19: An International Multi-center Study C-0007
6 · The paper itself

Abstract

AI is emerging as a promising tool for diagnosing COVID-19 based on chest CT scans. The aim of this study was the comparison of AI models for COVID-19 diagnosis. Therefore, we: (1) trained three distinct AI models for classifying COVID-19 and non-COVID-19 pneumonia (nCP) using a large, clinically relevant CT dataset, (2) evaluated the models' performance using an independent test set, and (3) compared the models both algorithmically and experimentally.In this multicenter multi-vendor study, we collected n=1591 chest CT scans of COVID-19 (n=762) and nCP (n=829) patients from China and Germany. In Germany, the data was collected from three RACOON sites. We trained and validated three COVID-19 AI models with different architectures: COVNet based on 2D-CNN, DeCoVnet based on 3D-CNN, and AD3D-MIL based on 3D-CNN with attention module. 991 CT scans were used for training the AI models using 5-fold cross-validation. 600 CT scans from 6 different centers were used for independent testing. The models' performance was evaluated using accuracy (Acc), sensitivity (Se), and specificity (Sp).The average validation accuracy of the COVNet, DeCoVnet, and AD3D-MIL models over the 5 folds was 80.9%, 82.0%, and 84.3%, respectively. On the independent test set with n=600 CT scans, COVNet yielded Acc=76.6%, Se=67.8%, Sp=85.7%; DeCoVnet provided Acc=75.1%, Se=61.2%, Sp=89.7%; and AD3D-MIL achieved Acc=73.9%, Se=57.7%, Sp=90.8%.The classification performance of the evaluated AI models is highly dependent on the training data rather than the architecture itself. Our results demonstrate a high specificity and moderate sensitivity. The AI classification models should not be used unsupervised but could potentially assist radiologists in COVID-19 and nCP identification. · This study compares AI approaches for diagnosing COVID-19 in chest CT scans, which is essential for further optimizing the delivery of healthcare and for pandemic preparedness.. · Our experiments using a multicenter, multi-vendor, diverse dataset show that the training data is the key factor in determining the diagnostic performance.. · The AI models should not be used unsupervised but as a tool to assist radiologists.. · Jaiswal A, Fervers P, Meng F et al. Performance of AI Approaches for COVID-19 Diagnosis Using Chest CT Scans: The Impact of Architecture and Dataset. Rofo 2026; 198: 185-198.

Indexed as

Artificial IntelligenceCOVID-19Radiography, ThoracicTomography, X-Ray ComputedAdultAgedAlgorithmsChinaDatasets as TopicFemaleGermanyHumansMaleMiddle AgedNeural Networks, ComputerPandemics

Identifiers

PMID40300640
PMCPMC12851823

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.